未登录 分享 收藏
分享 收藏
分享 收藏
A TROP2/Claudin program mediates immune exclusion to impede checkpoint blockade in breast cancer Wu, Bogang; Thant, Win; Bitman, Elena; Liu, Ting; Liu, Jie; Ilios, Eleftherios Paschalis; Xu, Katherine; Nieman, Linda; Ting, David; Thimmiah, Nayana; Sun, Sheng; Abelman, Rachel; Isakoff, Steven; Spring, Laura; Bardia, Aditya; Ellisen, Leif 分享 收藏
分享 收藏
分享 收藏
Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsies 三阴性乳腺癌(TNBC)患者中动态HER2-low状态及重复活检的影响 Bar, Yael; Fell, Geoffrey; Dedeoglu, Aylin; Moffett, Natalie; Vidula, Neelima; Spring, Laura; Wander, Seth A.; Bardia, Aditya; Ko, Naomi; Moy, Beverly; Ellisen, Leif W.; Isakoff, Steven J. 分享 收藏
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER) Spring, Laura M.; Scarpetti, Lauren; Medford, Arielle J.; Niemierko, Andrzej; Comander, Amy; Mulvey, Therese; Schnipper, Lowell; Isakoff, Steven J.; Moy, Beverly; Wander, Seth A.; Shin, Jennifer; Ephrem, Zanta; Laposta, Anneke R.; Denault, Elyssa; Abraham, Elizabeth; Calistro, Gayle; Kalashnikova, Ekaterina; Rodriguez, Angel; Liu, Minetta C.; Aleshin, Alexey; Peppercorn, Jeffrey; Ellisen, Leif W.; Bardia, Aditya 分享 收藏
分享 收藏
分享 收藏
Allosteric PI3K-alpha inhibition overcomes on-target resistance to orthosteric inhibitors mediated by secondary PIK3CA mutations Varkaris, Andreas; de la Cruz, Ferran Fece; Martin, Elizabeth; Nordern, Bryanna; Chevalier, Nicholas; Leshchiner, Ignaty; Stavridi, Anastasia; Kim, Janice; Papatheodoridi, Alkistis; Gunaydin, Hakan; Danysh, Brian; Parida, Laxmi; Sanidas, Ioannis; Ji, Yongli; Lau, Kayao; Wulf, Gerburg; Bardia, Aditya; Spring, Laura; Isakoff, Steven; Lennerz, Jochen; Pierce, Levi; Pazolli, Ermira; Getz, Gad; Corcoran, Ryan; Juric, Dejan 分享 收藏
Sequencing Antibody-Drug Conjugate after Antibody-Drug Conjugate in Metastatic Breast Cancer (A3 study): Multi-Institution Experience and Biomarker Analysis Abelman, Rachel Occhiogrosso; Spring, Laura; Fell, Geoffrey; Davis, Andrew; Hensing, Whitney; Ryan, Phoebe; Vidula, Neelima; Wander, Seth; Medford, Arielle; Shin, Jennifer; Abraham, Elizabeth; Isakoff, Steven; Moy, Beverly; Ellisen, Leif; Bardia, Aditya 分享 收藏
Personalized ctDNA testing for detection of molecular residual disease in patients with localized HR plus breast cancer: temporal dynamics and impact on clinical outcomes Medford, Arielle; Denault, Elyssa; Ephrem, Zanta; Micalizzi, Douglas; Bar, Yael; Abelman, Rachel; Comander, Amy; Knape, Justine; Liu, Minetta; Rodriguez, Angel; Isakoff, Steven; Moy, Beverly; Spring, Laura; Bardia, Aditya 分享 收藏
A first-inhuman study of the highly selective PI3Ka inhibitor RLY-5836 in patients with advanced breast cancer and other solid tumors Varkaris, Andreas; Isakoff, Steven; Perez, Cesar A.; O'Neil, Bert; Hamilton, Erika; Conlin, Erin; Tan, Gege; Li, Xiaoyan; Timm, Alison; Samadani, Ramin; Puente-Poushnejad, Erika; Kwak, Eunice; Mar, Brenton G.; Schram, Alison M. 分享 收藏
分享 收藏
Strategies to overcome resistance to PI3Kalpha-selective inhibitors mediated by acquired alterations in the PI3K/AKT pathway de la Cruz, Ferran Fece; Varkaris, Andreas; Martin, Elizabeth E.; Norden, Bryanna L.; Chevalier, Nicholas; Kehlmann, Allison M.; Leshchiner, Ignaty; Barnes, Haley; Ehnstrom, Sara; Patel, Parasvi; Kim, Janice S.; Ellis, Haley; Sanidas, Ioannis; Lau, Kayao T.; Bardia, Aditya; Spring, Laura M.; Isakoff, Steven J.; Lennerz, Jochen K.; Getz, Gad; Corcoran, Ryan B.; Juric, Dejan 分享 收藏
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial sacituzumab govitecan治疗局部三阴性乳腺癌的新辅助治疗: 来自NeoSTAR试验的结果 Spring, L. M.; Tolaney, S. M.; Fell, G.; Bossuyt, V.; Abelman, R. O.; Wu, B.; Maheswaran, S.; Trippa, L.; Comander, A.; Mulvey, T.; McLaughlin, S.; Ryan, P.; Ryan, L.; Abraham, E.; Rosenstock, A.; Garrido-Castro, A. C.; Lynce, F.; Moy, B.; Isakoff, S. J.; Tung, N.; Mittendorf, E. A.; Ellisen, L. W.; Bardia, A. 分享 收藏
分享 收藏
Intratumoral heterogeneity drives resistance to Antibody Drug Conjugate therapy: Analysis of the NeoSTAR trial of neoadjuvant Sacituzumab govitecan for localized TNBC Spring, Laura M.; Wu, Bogang; Liu, Ting; Geisberg, Jacob; Cristea, Simona; Bossuyt, Veerle; Abelman, Rachel Occhiogrosso; Peiris, Nicole; Coates, James; Koh, Siang-Boon; Zhang, Mengran; Ryan, Lianne; Moy, Beverly; Isakoff, Steven J.; Tolaney, Sara M.; Michor, Franziska; Bardia, Aditya; Ellisen, Leif W. 分享 收藏
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations 变构PI3Kα 抑制克服了继发性PIK3CA突变介导的对正构抑制剂的靶向抗性 Varkaris, Andreas; de la Cruz, Ferran Fece; Martin, Elizabeth E.; Norden, Bryanna L.; Chevalier, Nicholas; Kehlmann, Allison M.; Leshchiner, Ignaty; Barnes, Haley; Ehnstrom, Sara; Stavridi, Anastasia-Maria; Yuan, Xin; Kim, Janice S.; Ellis, Haley; Papatheodoridi, Alkistis; Gunaydin, Hakan; Danysh, Brian P.; Parida, Laxmi; Sanidas, Ioannis; Ji, Yongli; Lau, Kayao; Wulf, Gerburg M.; Bardia, Aditya; Spring, Laura M.; Isakoff, Steven J.; Lennerz, Jochen K.; Del Vecchio, Kathryn; Pierce, Levi; Pazolli, Ermira; Getz, Gad; Corcoran, Ryan B.; Juric, Dejan 分享 收藏